Chronic myeloid leukemia as an immunological target
- 1 January 1997
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 54 (1) , 61-67
- https://doi.org/10.1002/(sici)1096-8652(199701)54:1<61::aid-ajh9>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Generation of activated natural killer (A‐NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl‐positive targetsBritish Journal of Haematology, 1996
- Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.The Journal of Experimental Medicine, 1996
- Primary proliferative T cell response to wild‐type p53 protein in patients with breast cancerEuropean Journal of Immunology, 1995
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseBritish Journal of Haematology, 1995
- INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATIONTransplantation, 1994
- A new look for the 1990sNature, 1994
- SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIALTransplantation, 1994
- Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia — a phase II studyCancer Immunology, Immunotherapy, 1992
- Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1991
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979